Art

J-GLOBAL ID：201602286840334219   Reference number：16A0645159

Prognostic value of PET/CT with 18F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy

化学放射線療法を受けている頭頸部扁平上皮がん患者に対する¹⁸F-フルオロアゾマイシンアラビノシドを用いたPET/CTの予後予測的価値

Author (10)： Saga Tsuneo (Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan) ,  Inubushi Masayuki (Department of Nuclear Medicine, Kawasaki Medical School, Kurashiki, Japan) ,  Koizumi Mitsuru (Department of Nuclear Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Yoshikawa Kyosan (Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan) ,  Zhang Ming-Rong (Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan) ,  Obata Takayuki (Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan) ,  Tanimoto Katsuyuki (Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan) ,  Harada Rintaro (Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan) ,  Uno Takashi (Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan) ,  Fujibayashi Yasuhisa (Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan)
Material： Annals of Nuclear Medicine  (Ann Nucl Med)
Volume： 30  Issue： 3  Page： 217-224  Publication year： Apr. 2016 
JST Material Number： X0838A  ISSN： 0914-7187  CODEN： ANMEEX  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： combination therapy ,...
Semi thesaurus term： *lymphatic tumor ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0645159&from=J-GLOBAL&jstjournalNo=X0838A") }}

Author keywords (5)： Head and neck squamous cell carcinoma ,  18F-fluoroazomycin arabinoside (FAZA) ,  Positron emission tomography/computed tomography (PET/CT) ,  Chemoradiotherapy ,  Prognosis

JST classification (3)： Diagnosis of tumors(=neoplasms)  (GE03020J) ,  Tumors(=neoplasms)of musculoskeletal system  (GG04000A) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Reference (27)：

• Brown JM. The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain memorial award lecture. Cancer Res. 1999;59:5863-70.
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721-32.
• Krohn KA, Link JM, Mason RP. Molecular imaging of hypoxia. J Nucl Med. 2008;49:129S-48S.
• Nordsmark M, Overgaart M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1996;41:31-9.
• Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhist MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285-9.

Terms in the title (7)： 化学放射線療法 ,  頭頸部扁平上皮がん ,  患者 ,  PET ,  CT ,  予後予測 ,  価値